{"SPADE_UN_16995": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16995", "Peptide Name": "YTA2", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "YTAIAWVKAFIRKLRK", "Sequence Length": 16, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "fluorescein", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C95H154N26O19", "Mass": 1964.4, "PI": 11.17, "Net Charge": 5, "Hydrophobicity": 0.1, "Half Life": "Mammalian:2.8 hourYeast:10 minE.coli:2 min", "Literature": [{"Title": "Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide.", "Pubmed ID": "16376307", "Reference": "Biochem Pharmacol. 2006 Feb 14;71(4)416-25.", "Author": "Lindgren M, Rosenthal-Aizman K, Saar K, Eiríksdóttir E, Jiang Y, Sassian M, Ostlund P, Hällbrink M, Langel U.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=16376307"}], "Frequent Amino Acids": "AKI", "Absent Amino Acids": "CDEGHMNOPQSU", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 10, "Polar Residues": 11, "Positive Residues": 5, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_17033", "Similarity": 1.0, "Sequence": "IAWVKAFIRKLRKGPLG"}, {"SPADE_ID": "SPADE_UN_26117", "Similarity": 1.0, "Sequence": "RKLRKKVFVKRV"}, {"SPADE_ID": "SPADE_UN_04239", "Similarity": 1.0, "Sequence": "KLRKRLKKFRNSIKKRLKNFN"}]}}}